Htr7 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute | Value |
|---|---|
| Gene Symbol | HTR7 |
| Full Name | 5-Hydroxytryptamine Receptor 7 |
| Chromosomal Location | 10q21.3 |
| NCBI Gene ID | 3363 |
| Ensembl ID | ENSG00000148680 |
| UniProt ID | P34969 |
| Gene Family | 5-HT7 receptor family (GPCR) |
| Protein Class | G protein-coupled receptor |
| Brain Expression | Hippocampus, Hypothalamus, Cortex, Thalamus |
The HTR7 gene encodes the 5-hydroxytryptamine receptor 7 (5-HT7), a G protein-coupled receptor (GPCR) that plays crucial roles in circadian rhythm regulation, sleep-wake cycles, mood, and cognitive function. The 5-HT7 receptor is unique among serotonin receptors as it primarily couples to Gs proteins, increasing cAMP levels. This receptor has emerged as a therapeutic target for depression, sleep disorders, and potentially for neurodegenerative diseases including Alzheimer's and Parkinson's disease.
The 5-HT7 receptor exhibits distinctive pharmacological and signaling properties:
The receptor shares the classic seven-transmembrane domain structure of GPCRs:
The 5-HT7 receptor shows widespread but specific distribution:
| Brain Region | Expression | Function |
|---|---|---|
| Hypothalamus | Very High | Circadian regulation, thermoregulation |
| Hippocampus | High | Memory, synaptic plasticity |
| Cortex | High | Cognition, mood |
| Thalamus | High | Sensory processing |
| Suprachiasmatic Nucleus | High | Circadian pacemaker |
| Amygdala | Moderate | Emotional processing |
| Compound | Type | Development | Indication |
|---|---|---|---|
| AS-19 | Agonist | Research tool | Circadian disorders |
| LP-211 | Agonist | Research tool | Neuroprotection |
| SB-269970 | Antagonist | Research tool | Depression, migraine |
| Cariprazine | Antagonist | Approved | Schizophrenia, bipolar |
The study of Htr7 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Hedlund PB, Sutcliffe JG. The 5-HT7 receptor influences stereotypic behavior in rats. Psychopharmacology (Berl). 2004;173(3-4):167-173. PMID:14657021
[2] Wesołowska A. In vitro and in vivo characterization of the 5-HT7 receptor antagonist SB-269970. Pol J Pharmacol. 2004;56(1):49-55. PMID:15852389
[3] Monti JM. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):320-334. PMID:20091054